Alzheimer's disease, the most common form of dementia, is considered a disease of old age. But an unlikely group of 400,000 ...

In a preclinical study, Cedars-Sinai investigators found that boosting angiotensin-converting enzyme (ACE) in key immune ...

Two already-approved medications may help overturn brain changes caused by Alzheimer's disease, according to a recent study ...

A new preclinical study has found exposure to nanoplastics may contribute to the rapid progression of Alzheimer's disease and ...

The early signs of Alzheimer's disease—more frequent memory loss, increased confusion—can be difficult to detect, often ...

A longitudinal study at Johns Hopkins that began in 1995 depends on the dedication of hundreds of people as well as NIH ...

Patients could have four more years of good health on the new drug while trial users have seen cognitive improvements too ...

A history of traumatic brain injury was linked to long-term cognitive decline involving speech functions, specifically where ...

Helen Dennis is a nationally recognized leader on issues of aging and the new retirement with academic, corporate and ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

There are currently estimated to be 982,000 people with some form of dementia, including Alzheimer's in the UK ...

The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment ...